NENiels Ejskjaer

Niels Ejskjaer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Niels Ejskjaer has a total of 261 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Gout as a risk factor for lower-extremity amputation in diabetes: a nationwide, register-based case–control study

    by Johan Røikjer, Annika Vestergaard Kvist, Peter Derek Christian Leutscher, Niels Ejskjaer, Claus Rasmussen

  • Associations of video head impulse test and computerized dynamic posturography with self-reported falls and postural control in people with diabetes: an exploratory cross-sectional study

    by Aksayan Arunanthy Mahalingasivam, Emma Øster Fossá, Aria Monica Zahidi, Anne Lindahl Asmussen, Johan Rosenblad Laursen, Niels Ejskjaer, Dan Dupont Hougaard, Peter Vestergaard, Johan Røikjer, Nicklas Højgaard-Hessellund Rasmussen

  • Open Access

    Sleep quality and diabetic neuropathy: A review and exploratory meta-analysis

    by Omar Alsatam Alraoui, Mette Krabsmark Borbjerg, David C. Klonoff, Carsten Dahl Mørch, Daniel Ciampi de Andrade, Niels Ejskjaer, Johan Røikjer


  • Open Access

    Impaired Dynamic Postural Control in People with Diabetes: An Exploratory Cross-Sectional Study Using Computerized Dynamic Posturography (Bertec)

    by Asger Krohn Jespersen, Aksayan Arunanthy Mahalingasivam, Niels Ejskjær, Dan Dupont Hougaard, Peter Vestergaard, Johan Røikjer, Nicklas Højgaard-Hessellund Rasmussen

    BACKGROUND: This study assessed static and dynamic postural control in individuals with type 1 (T1D) and type 2 diabetes (T2D) using Computerized Dynamic Posturography (Bertec), hypothesizing that diabetes, especially with diabetic peripheral neuropathy (DPN), leads to significant impairments in postural stability. METHODS: A total of 94 participants with diabetes (T1D: n=49, T2D: n=45) and 94 age- and sex-matched controls underwent postural assessments using the Sensory Organization Test (SOT) and Motor Control Test (MCT). The SOT evaluated sensory system contributions (somatosensory,visual, vestibular), while the MCT assessed postural recovery responses. RESULTS: Both T1D and T2D groups exhibited impaired SOT performance compared to controls (P < .05). Type 1 diabetes showed impaired visual function (P < .05), while both groups demonstrated poorer postural stability in conditions requiring vestibular input (P < .05) and slower MCT response times (10 of 14 abnormal, P < .05). T2D participants relied excessively on visual input (preference function: P < .05). No significant associations were detected between DPN, body mass index, Hemoglobin A1c (HbA1c), or diabetes duration with postural control impairments. CONCLUSION: Diabetes impairs postural control, particularly in conditions that rely heavily on vestibular and visual inputs, regardless of DPN. Advanced tools like Bertec reveal real-world deficits, highlighting the potential value of these findings in informing future fall-prevention strategies for individuals with diabetes.


  • Open Access

    Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study

    by Mette K. Borbjerg, Sara Mokhtar, Nadia Sutedja, Annemarie Koster, Carsten D. Mørch, Tos T. J. M. Berendschot, Nicolaas Schaper, Niels Ejskjaer, Johan Røikjer

    Aims/hypothesis: Corneal confocal microscopy is a valuable technique for assessing neuropathy; however, whether it can distinguish painful from painless neuropathy remains uncertain and existing evidence is based on the results of smaller studies. This study assessed the association of corneal nerve parameters with abnormalities identified by electromyography (EMG) and neuropathic pain in a large population with and without (pre)diabetes. Methods: In this study we included cross-sectional data for 3425 participants from the Maastricht Study. Wide-field corneal confocal microscopy (WF-CCM) was performed using fully automated analysis of three corneal nerve parameters: corneal nerve branch density (CNBD), corneal nerve fibre density (CNFD) and corneal nerve fibre length (CNFL). An axonal degeneration composite score comprising compound muscle action potential amplitudes (peroneal and tibial) and the sensory nerve action potential amplitude of the sural nerve was created by categorising EMG amplitudes as normal or indicating minor (≤10th percentile), moderate (≤5th percentile) or severe (≤2.5th percentile) abnormalities. Neuropathic pain was determined as a modified Douleur Neuropathique en 4 Questions (DN4) interview score ≥3. Results: The mean age of the participants was 59.2 years; 51.6% were female, 15% had prediabetes (defined as impaired fasting glucose, impaired glucose tolerance or both) and 19% had type 2 diabetes. The median diabetes duration was 3.0 years. Regression analyses revealed statistically significant associations between the axonal degeneration EMG score and WF-CCM parameters (CNFL: β=−0.51 [95% CI −0.78, −0.24]; CNFD: β=−1.56 [95% CI −3.04, −0.08]; CNBD: β=−3.08 [95% CI −5.51, −0.64]; all p 0.1). Conclusions/interpretation: The study found associations between the axonal degeneration EMG score and WF-CCM, but no associations were observed between neuropathic pain and WF-CCM parameters, suggesting that WF-CCM has limited value in assessing neuropathic pain. Graphical


  • Corneal Immune Cells and Their Relation to Diabetic Peripheral Neuropathy and Neuropathic Pain

    by Fatme Moussa, Sarah Taleb, Mette Krabsmark Borbjerg, Suganthiya Santhiapillai Croosu, Carsten Dahl Mørch, Jens Brøndum Frøkjær, Tine Maria Hansen, Niels Ejskjaer, Johan Røikjer

    Introduction/Aims: As corneal dendritic cells (DCs) are immune cells that can reflect systemic inflammatory activity, this study aimed to investigate whether the density and maturity of corneal DCs are associated with diabetes, diabetic peripheral neuropathy (DPN), and neuropathic pain. Methods: Participants included individuals with type 1 diabetes mellitus (T1DM) and painful DPN ( n = 19), T1DM and painless DPN ( n = 15), T1DM without DPN ( n = 19), and healthy controls ( n = 20). Corneal confocal microscopy was used to quantify and categorize DCs as either mature or immature and based on their proximity to corneal nerves. Results: No significant differences between groups were observed in total DC density ( p = 0.34). Subgroup analysis revealed distinct patterns in which participants with DPN (regardless of pain status) exhibited a higher density of immature DCs distant from corneal nerves compared to those without DPN (14.4 [6.64–37.5] vs. 3.75 [0–17.7] no./mm 2 , p < 0.05). Healthy controls had a greater density of immature DCs near the nerves compared to the T1DM + DPN group (2.8 [0–8.44] vs. 8.3 [3.12–15.1] no./mm 2 ), while the T1DM + DPN group had a higher density than the painful DPN (3.1 [1.25–5.62] no./mm 2 ). For mature DCs near the nerves, individuals with painful DPN (2.5 [1.4–3.12] no./mm 2 ) had a lower density compared to all other groups. Discussion: This study demonstrates distinct patterns of corneal DC distribution in relation to painful and painless DPN. The findings suggest that immune‐mediated mechanisms may play a role in the development of neuropathy and neuropathic pain in diabetes. The pathophysiological significance remains to be clarified. Trial Registration: ClinicalTrials.gov: NCT04078516.


  • Symptom-driven co-existence of diabetic autonomic neuropathy, peripheral neuropathy, and painful neuropathy

    by Johan Røikjer, Mette Krabsmark Borbjerg, Maria Bitsch Poulsen, Amar Nikontovic, Niels Ejskjaer, Peter Vestergaard, Christina Brock

    Aims Diabetic Autonomic Neuropathy (DAN) and Diabetic Peripheral Neuropathy (DPN) are distinct complications of diabetes, but their co-existence remains underexplored. This study aimed to investigate the symptom-driven co-existence of DAN, DPN, and painful DPN. Methods In November 2022, an electronic survey was distributed to everyone with diabetes in the North Denmark Region (n = 29,155). The survey included demographic data, and validated questionnaires: the Michigan Neuropathy Screening Instrument (MNSI), Composite Autonomic Symptom Score-31 (COMPASS-31), and Douleur Neuropathique 4 Interview (DN4i). DPN was defined as MNSI ≥ 4, painful DPN as bilateral foot pain with DN4i ≥ 3, and DAN as COMPASS-31 ≥ 16. DAN was further stratified into: symptoms of autonomic dysfunction (SAD)- (< 16), SAD + (16–31), and SAD + + (≥ 32). Results Of 9,913 respondents, 7,321 provided complete data. Mean age was 64.8 yearsand 86.3% had type 2 diabetes. DPN prevalence among those with DAN was 44.6% in type 1 and 39.6% in type 2 diabetes. DPN prevalence rose with DAN severity: 11.1% in SAD-, 26.4% in SAD + , and 58.6% in SAD + + (p < 0.01). Painful DPN followed a similar trend, increasing from 8.0% in SAD- to 50.2% in SAD + + (p < 0.01). Linear regression demonstrated a strong association between COMPASS-31 and MNSI scores (p < 0.001), indicating that higher autonomic symptom burden was associated with greater severity of peripheral neuropathy. Conclusions DAN, DPN, and painful DPN frequently co-exist. Increasing DAN symptom severity is associated with higher prevalence of both DPN and neuropathic pain and showed a strong linear association with the severity of peripheral DPN, suggesting shared pathophysiological mechanisms beyond isolated small fiber involvement.


  • Response to Letter to the Editor: Concerns about generalizability in MRI-based neuropathy classification

    by Søren Nf. Hostrup, Suganthiya S. Croosu, Johan Røikjer, Niels Ejskjær, Jens B. Frøkjær

  • Open Access

    Multimodal MRI analysis selecting key brain features for machine learning based classification of diabetic neuropathic pain and phenotypes

    by Søren Nf. Hostrup, Henrik P. Lind, Suganthiya S. Croosu, Johan Røikjer, Carsten D. Mørch, Niels Ejskjær, Lasse R. Østergaard, Tine M. Hansen, Jens B. Frøkjær


  • Machine Learning to Diagnose Complications of Diabetes

    by Agatha F. Scheideman, Mandy M. Shao, Henry Zelada, Jorge Cuadros, Joshua Foreman, Pinaki Sarder, Cindy Ho, Niels Ejskjaer, Jesper Fleischer, Simon Lebech Cichosz, et al.

    Machine learning (ML) uses computer systems to develop statistical algorithms and statistical models that can draw inferences from demographic data, structured behavioral data, continuous glucose monitor (CGM) tracings, laboratory data, cardiovascular and neurological physiology measurements, and images from a variety of sources. ML is becoming increasingly used to diagnose complications of diabetes based on these types of datasets. In this article, we review the current status, barriers to progress, and future prospects for using ML to diagnose seven complications of diabetes, including five traditional complications, one set of other systemic complications, and one prediction that can result in favorable or unfavorable outcomes. The complications include (1) diabetic retinopathy, (2) diabetic nephropathy, (3) peripheral neuropathy, (4) autonomic neuropathy, (5) diabetic foot ulcers, and (6) other systemic complications. The prediction is for outcomes in hospitalized patients with diabetes. ML for these purposes is in its infancy, as evidenced by only a limited number of products having received regulatory clearance at this time. However, as multicenter reference datasets become available, it will become possible to train algorithms on increasingly larger and more complex datasets and patterns so that diagnoses and predictions will become increasingly accurate. The use of novel choices of images and imaging technologies will contribute to progress in this field. ML is poised to become a widely used tool for the diagnosis of complications and predictions of outcomes and glycemia in people with diabetes.